Clinical Trial Update: Artelon Metatarsophalangeal (MTP) Spacer [Phase 4]

View source ↗

Summary

Clinical trial update for the Artelon MTP Spacer from Artimplant AB in osteoarthritis and hallux rigidus; Phase 4 status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hallux Rigidus
• Osteoarthritis

Drugs mentioned

• Artelon MTP Spacer

Snippet

Sponsor: Artimplant AB | Conditions: Osteoarthritis, Hallux Rigidus | Phase 4 | Status: UNKNOWN